Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease

Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease

Purpose: Cholestatic liver diseases are groups of hepatobiliary diseases without curative drug-based therapy options. Regulation of bile acid (BA) metabolism, hepatoperiductal fibrosis, and inflammatory response indicated present novel methods for the treatment of cholestatic liver disease. Costunol...

Full description

Bibliographic Details
Main Authors:	Juan Hao, Xiaoyu Shen, Kan Lu, Yi Xu, Yiyue Chen, Jibo Liu, Xiaohong Shao, Chunling Zhu, Yaqin Ding, Xin Xie, Jian Wu, Quanjun Yang
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Journal of Traditional and Complementary Medicine
Subjects:	Costunolide Cholestatic liver disease Bile acid metabolism Inflammatory response Ductular reaction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2225411023000226

Similar Items

Reversine attenuates cholestatic ductular reaction in rats
by: Di Huang, et al.
Published: (2023-05-01)

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
by: Tianhao Zhou, et al.
Published: (2021-08-01)

Honokiol attenuates ductular reaction, regulates of bile acids metabolism, and inhibits inflammatory response in murine cholestatic liver injury model
by: Juan Hao, et al.
Published: (2023-08-01)

Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease
by: Linzhang Zhang, et al.
Published: (2022-10-01)

Cardiorenal Protective Effect of Costunolide against Doxorubicin-Induced Toxicity in Rats by Modulating Oxidative Stress, Inflammation and Apoptosis
by: Wen Xing, et al.
Published: (2022-03-01)

Alleviating sepsis: Revealing the protective role of costunolide in a cecal ligation and puncture rat model
by: Mustafa Güler, et al.
Published: (2024-05-01)

Costunolide: A novel anti-cancer sesquiterpene lactone
by: Azhar Rasul, et al.
Published: (2012-03-01)

Ductular Reactions in Liver Injury, Regeneration, and Disease Progression—An Overview
by: Nirmala Mavila, et al.
Published: (2024-03-01)

Dynamics of germination stimulants dehydrocostus lactone and costunolide in the root exudates and extracts of sunflower
by: Wenlong Wu, et al.
Published: (2022-12-01)

Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer
by: Ali H. El-Far, et al.
Published: (2021-08-01)

Costunolide prevents renal ischemia-reperfusion injury in rats by reducing autophagy, apoptosis, inflammation, and DNA damage
by: Mustafa Güler, et al.
Published: (2023-10-01)

Gypenosides ameliorate ductular reaction and liver fibrosis via inhibition of hedgehog signaling
by: Yonghong Hu, et al.
Published: (2022-11-01)

Scoparone attenuates cholestatic liver injury through regulating hepatic bile acid metabolism, ameliorating periductal fibrosis and inhibiting inflammatory response
by: Juan Hao, et al.
Published: (2023-09-01)

Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis
by: Ya Yang, et al.
Published: (2022-02-01)

Granulocyte colony-stimulating factor reduces biliary fibrosis and ductular reaction in a mouse model of chronic cholestasis
by: Trinh Van Le, et al.
Published: (2023-03-01)

Mucosal-associated invariant T cells promote ductular reaction through amphiregulin in biliary atresiaResearch in context
by: Man-Huan Xiao, et al.
Published: (2024-05-01)

Protective Effects of Costunolide against Hydrogen Peroxide-Induced Injury in PC12 Cells
by: Chong-Un Cheong, et al.
Published: (2016-07-01)

Emodin alleviates cholestatic liver injury by modulating Sirt1/Fxr signaling pathways
by: Zhi Hu, et al.
Published: (2024-07-01)

Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment
by: Hao Fu, et al.
Published: (2024-07-01)

Costunolide Plays an Anti-Neuroinflammation Role in Lipopolysaccharide-Induced BV2 Microglial Activation by Targeting Cyclin-Dependent Kinase 2
by: Yan-Chen Liu, et al.
Published: (2020-06-01)

Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway
by: Zhao Y, et al.
Published: (2024-07-01)

Alpha-ketoglutarate alleviates cholestatic liver injury in mice
by: XIE Yuhong, et al.
Published: (2022-07-01)

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer
by: Xueli Tian, et al.
Published: (2022-10-01)

The gut microbiota-bile acid axis in cholestatic liver disease
by: Dayan sun, et al.
Published: (2024-07-01)

Therapeutic Effect of Costunolide in Autoimmune Hepatitis: Network Pharmacology and Experimental Validation
by: Zheng Huang, et al.
Published: (2023-02-01)

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
by: Jingxin Mao, et al.
Published: (2018-12-01)

Yap signalling regulates ductular reactions in mice with CRISPR/Cas9-induced glycogen storage disease type Ia
by: Yixia Xie, et al.
Published: (2022-11-01)

Cholestatic hepatitis induced by atorvastatin: a case-report
by: M. Vergura, et al.
Published: (2013-05-01)

Cholestatic Liver Injury in a Patient with Tertiary Syphilis
by: Sahaj Mujumdar, et al.
Published: (2022-09-01)

Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
by: Andrea Villar-Lorenzo, et al.
Published: (2019-07-01)

β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction
by: Shikai Hu, et al.
Published: (2021-10-01)

Costunolide ameliorates rotenone-induced Parkinson's disease in rat model via activation of SIRT-1/p-AMPK cascade and suppression of IL-6/STAT3 axis
by: Alaa Sirwi, et al.
Published: (2024-12-01)

Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling
by: Huiling Cao, et al.
Published: (2024-01-01)

Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
by: Antonia Greimel, et al.
Published: (2023-11-01)

The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction
by: Bowen Yang, et al.
Published: (2022-05-01)

Quercetin 7-rhamnoside protects against alpha-naphthylisothiocyanate (ANIT)-induced in cholestatic hepatitis rats by improving biliary excretion and inhibiting inflammatory responses
by: Hong-Liu Jin, et al.
Published: (2023-01-01)

CD24+LCN2+ liver progenitor cells in ductular reaction contributed to macrophage inflammatory responses in chronic liver injury
by: Wei-Jian Huang, et al.
Published: (2023-10-01)

The Role of Inflammation in Cholestatic Liver Injury
by: Chen J, et al.
Published: (2023-10-01)

Ursodeoxycholic acid therapy in children with cholestatic liver disease
by: Gönül Dinler, et al.
Published: (1999-01-01)

Cholestatic jaundice in a sample of Iraqi Infants (A hospital based study)
by: Sawsan I. Al-Azzawi, et al.
Published: (2011-04-01)